Therefore, with this study, we report our short- and long-term results on using t-PA as the first-line therapy in HVAD thrombosis with implementation of a standardized, institutional protocol [institutional standardized HVAD pump thrombosis lysis protocol (ISHP)]. The gene discussed is PLAT; the disease is deep vein thrombosis.